Get the Stockscreener App
5.94
5.13%
0.29
After Hours:
5.77
-0.17
-2.86%
Chromadex Corp stock is traded at $5.94, with a volume of 352.72K.
It is up +5.13% in the last 24 hours and down -1.00% over the past month.
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.
See More
Previous Close:
$5.65
Open:
$5.69
24h Volume:
352.72K
Relative Volume:
0.28
Market Cap:
$448.70M
Revenue:
$83.57M
Net Income/Loss:
$-4.94M
P/E Ratio:
-84.86
EPS:
-0.07
Net Cash Flow:
$6.97M
1W Performance:
+12.71%
1M Performance:
-1.00%
6M Performance:
+104.12%
1Y Performance:
+315.38%
1-Day Range:
$5.65
$6.03
1-Week Range:
$5.17
$6.03
52-Week Range:
$1.36
$7.9738
Chromadex Corp Stock (CDXC) Company Profile
Name
Chromadex Corp
Sector
Industry
Phone
310-388-6706
Address
10900 WILSHIRE BLVD, LOS ANGELES
Compare CDXC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDXC
Chromadex Corp
|
5.94 | 448.70M | 83.57M | -4.94M | 6.97M | -0.07 |
|
KHC
Kraft Heinz Co
|
29.27 | 35.54B | 26.13B | 1.37B | 3.00B | 1.11 |
|
GIS
General Mills Inc
|
59.63 | 32.87B | 19.90B | 2.60B | 2.80B | 4.60 |
|
K
Kellanova Co
|
81.78 | 28.11B | 12.80B | 1.01B | 927.00M | 2.91 |
|
MKC
Mccormick Co Inc
|
73.31 | 19.67B | 6.68B | 792.60M | 774.40M | 2.94 |
|
HRL
Hormel Foods Corp
|
29.93 | 16.43B | 11.92B | 805.04M | 1.01B | 1.46 |
Chromadex Corp Stock (CDXC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-16-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Aug-11-22 | Downgrade | B. Riley Securities | Buy → Neutral |
| Mar-08-22 | Initiated | ROTH Capital | Buy |
| Oct-16-19 | Initiated | Oppenheimer | Outperform |
| Feb-14-19 | Initiated | B. Riley FBR | Buy |
| Nov-27-17 | Resumed | H.C. Wainwright | Buy |
| Sep-25-17 | Initiated | Ladenburg Thalmann | Buy |
| Jan-03-17 | Initiated | Rodman & Renshaw | Buy |
View All
Chromadex Corp Stock (CDXC) Latest News
Short Interest in ChromaDex Co. (NASDAQ:CDXC) Grows By 6.7% - MarketBeat
StockNews.com Downgrades ChromaDex (NASDAQ:CDXC) to Buy - MarketBeat
ChromaDex (NASDAQ:CDXC) Rating Lowered to “Buy” at StockNews.com - Defense World
Jane Street Group LLC Has $167,000 Position in ChromaDex Co. (NASDAQ:CDXC) - Defense World
ChromaDex (NASDAQ:CDXC) Share Price Crosses Above 200-Day Moving Average – Here’s What Happened - Defense World
ChromaDex (NASDAQ:CDXC) Shares Pass Above 200-Day Moving AverageWhat's Next? - MarketBeat
ChromaDex Corp Partners with Persona Nutrition, Expanding Global Partnership with Nestlé Health Science - Marketscreener.com
ChromaDex to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025 - Business Wire
Barclays PLC Purchases 53,472 Shares of ChromaDex Co. (NASDAQ:CDXC) - Defense World
Geode Capital Management LLC Raises Holdings in ChromaDex Co. (NASDAQ:CDXC) - Defense World
ChromaDex (NASDAQ:CDXC) Downgraded to Buy Rating by StockNews.com - Defense World
ChromaDex (NASDAQ:CDXC) Stock Rating Lowered by StockNews.com - MarketBeat
Franklin Resources Inc. Takes Position in ChromaDex Co. (NASDAQ:CDXC) - Defense World
State Street Corp Purchases 62,692 Shares of ChromaDex Co. (NASDAQ:CDXC) - Defense World
ChromaDex (NASDAQ:CDXC) Shares Cross Above 200-Day Moving Average – Here’s What Happened - Defense World
ChromaDex (NASDAQ:CDXC) Share Price Passes Above Two Hundred Day Moving AverageHere's Why - MarketBeat
The Zacks Analyst Blog Highlights ADMA Biologics, Tarsus Pharmaceuticals, Stoke Therapeutics, Inc. and ChromaDex - Yahoo Finance
StockNews.com Upgrades ChromaDex (NASDAQ:CDXC) to “Strong-Buy” - Defense World
Fmr LLC Takes Position in ChromaDex Co. (NASDAQ:CDXC) - Defense World
ChromaDex (NASDAQ:CDXC) Stock Rating Upgraded by StockNews.com - MarketBeat
4 Drug, Biotech Stocks Rising More Than 50% In 2024 With Room To Grow - Barchart
4 Drug, Biotech Stocks Rising More Than 50% in 2024 With Room to Grow - Yahoo Finance
The Manufacturers Life Insurance Company Has $72,000 Position in ChromaDex Co. (NASDAQ:CDXC) - Defense World
ChromaDex (NASDAQ:CDXC) Lowered to Buy Rating by StockNews.com - Defense World
ChromaDex (NASDAQ:CDXC) Lowered to "Buy" Rating by StockNews.com - MarketBeat
ChromaDex appoints Crowe as new auditor - Investing.com
ChromaDex appoints Crowe as new auditor By Investing.com - Investing.com Canada
BNP Paribas Financial Markets Increases Position in ChromaDex Co. (NASDAQ:CDXC) - Defense World
Frank L. Jaksch, Jr. Sells 37,161 Shares of ChromaDex Co. (NASDAQ:CDXC) Stock - MarketBeat
Chromadex director Frank Jaksch sells $229,955 in stock - Investing.com
MetLife Investment Management LLC Acquires 5,115 Shares of ChromaDex Co. (NASDAQ:CDXC) - Defense World
Even though ChromaDex (NASDAQ:CDXC) has lost US$73m market cap in last 7 days, shareholders are still up 389% over 1 year - Yahoo Finance
ChromaDex (NASDAQ:CDXC) Upgraded by StockNews.com to Strong-Buy Rating - Defense World
ChromaDex (CDXC) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance
ChromaDex (NASDAQ:CDXC) Shares Gap UpTime to Buy? - MarketBeat
ChromaDex maintains Buy rating on recent agreement By Investing.com - Investing.com Canada
ChromaDex maintains Buy rating on recent agreement - Investing.com
ChromaDex Named to the Inc. 2024 Best in Business List in the Health Products Category - The Bakersfield Californian
ChromaDex Named to Inc. 2024 Best in Business List for Health Products Innovation - StockTitan
ChromaDex stock soars to 52-week high, hits $7.87 By Investing.com - Investing.com Nigeria
ChromaDex stock soars to 52-week high, hits $7.87 - Investing.com
Tru Niagen’s Canadian retail footprint now includes Whole Foods in Ontario - NutraIngredients-usa.com
ChromaDex Co. (NASDAQ:CDXC) CFO Ozan Pamir Buys 2,907 Shares - MarketBeat
Chromadex CFO Pamir Ozan acquires $21,396 in company stock By Investing.com - Investing.com Australia
Chromadex CFO Pamir Ozan acquires $21,396 in company stock - Investing.com India
Insider Buying: Ozan Pamir Acquires Shares of ChromaDex Corp (CD - GuruFocus.com
ChromaDex (NASDAQ:CDXC) Shares Down 5.5%What's Next? - MarketBeat
ChromaDex Corporation (CDXC) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Chromadex Corp Stock (CDXC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.15%
0.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):